QIAGEN DNA Synthesis AB
Org.nr556378-5046
Telefon010-474 93 00
AdressPressduktorgränd 6, 721 36 VÄSTERÅS
At QIAGEN DNA Synthesis AB, we know that high-quality, pure oligonucleotides can make a difference. We manufacture premium quality custom oligos in small to large scale for molecular and in-vitro diagnostic applications. Critical raw materials are tested and approved before use in bulk production for lot-to-lot reproducibility. Synthesis processes are optimized and automated to meet stringent requirements, including a no-contamination guarantee for IVD-grade. Moreover, we work according to cGMP/QSR guidelines in ISO-certified facilities, providing full traceability with extensive Production Batch Records.
Indikatorer
Kassalikviditet
Inte tillfredsst.
28,4 %2021:Inte tillfredsst. 22,2 %
Vinstmarginal
Inte tillfredsst.
−61,5 %2021:Inte tillfredsst. −34,5 %
Soliditet
Tillfredsst.
11,9 %2021:Svag 8,6 %
Källa: UC AB
Nyckeltal
| 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 | ||
|---|---|---|---|---|---|---|
| Vinstmarginal i % | −61,5 | −34,5 | −4,5 | −6,4 | 11 | |
| Kassalikviditet i % | 28,4 | 22,2 | 42 | 41,6 | 288,2 | |
| Soliditet i % | 11,9 | 8,6 | 31,8 | 58 | 88,3 | |
| Skuldsättningsgrad | 7,4 | 10,7 | 2,1 | 0,7 | 0,1 | |
| Avkastning eget kapital | −280,4 | −267 | −15,6 | −11,1 | 12,4 | |
| Avkastning totalt kapital | −30,2 | −21,1 | −3,9 | −5,9 | 11 | |
| Anställda | 105 | 97 | 91 | 72 | 62 |
